PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportspremenstrual syndrome
MeSH D011293 - premenstrual syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008599:Menstruation disturbances
$
Success rate
D011293: 
Premenstrual syndrome
D065446:Premenstrual dysphoric disorder
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsIbuprofen Ibu  1989-12-18   
Ibuprofen Ibuprofen  1985-06-14   
AbbVieIbuprofen, Hydrocodone Vicoprofen  1997-09-23   
Alkem LaboratoriesIbuprofen Ibuprofen  2021-09-13   
Famotidine, Ibuprofen Ibuprofen Famotidine  2021-08-03   
AllerganIbuprofen, Hydrocodone Hydrocodone Ibuprofen  2003-12-31   
Ibuprofen Ibuprofen  1985-09-06   
Oxycodone, Ibuprofen Oxycodone Ibuprofen  2007-11-26   
AlraIbuprofen Ibu-tab  1988-08-11   
Amneal PharmaceuticalsIbuprofen Ibuprofen  1987-02-17   
Ibuprofen, Hydrocodone Reprexain  2004-03-18   
ANI PharmaceuticalsIbuprofen, Hydrocodone Hydrocodone Ibuprofen  2010-06-23   
Ibuprofen Ibuprofen  1987-01-20   
Annora PharmaIbuprofen Ibuprofen  2018-11-23   
Ascent PharmaceuticalsIbuprofen Ibuprofen  2017-12-21   
Famotidine, Ibuprofen Ibuprofen Famotidine  2023-03-15   
Aurobindo PharmaIbuprofen Ibuprofen  2018-06-29   
Ibuprofen, Diphenhydramine Ibuprofen Diphenhydramine  2019-02-14   
Ibuprofen, Pseudoephedrine Ibuprofen Pseudoephedrine  2017-12-01   
Acetaminophen, Ibuprofen Acetaminophen Ibuprofen  2024-03-26   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
50%
3/6
Phase 2
83%
5/6
Phase 3
50%
5/10
Approved: 3Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Allergan
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use